SCHEMBL208990

SCHEMBL208990

O=C(O)CNC(=O)C1=CCCO1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
MAPK1 P28482 2/20 0.46
APEX1 P27695 1/20 0.41
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
HIF1A Q16665 1/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
SLC22A8 Q8TCC7 1/20 0.40
ALDH1A1 P00352 4/20 0.39
RAB9A P51151 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
TSHR P16473 1/20 0.39
NPC1 O15118 1/20 0.37
KMT2A Q03164 2/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
EGLN1 Q9GZT9 1/20 0.35
EGLN2 Q96KS0 1/20 0.35
FTO Q9C0B1 1/20 0.35
MME P08473 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13113179 0.81 NPC1 (0.33) KDM4EMAPK1RAB9ANPC1
SCHEMBL14468186 0.73
SCHEMBL24447 0.72
SCHEMBL19310541 0.66
SCHEMBL6128389 0.66
SCHEMBL3105012 0.66
SCHEMBL5256551 0.65 TRPV1 (0.43) MAPTHIF1ARAB9ANPC1KMT2A
SCHEMBL24906139 0.64 KDM4E (0.40) KDM4EMAPK1APEX1POLBMAPT
SCHEMBL23974340 0.64 KDM4E (0.40) KDM4EMAPK1APEX1POLBMAPT
SCHEMBL29044988 0.64 HDAC6 (0.47) ALDH1A1CA1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7812044-B2 Anticancer agents TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-10-12 US claimed
EP-2094246-B1 SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME TAKEDA PHARMACEUTICALS CO (JP) 2020-04-01 EP disclosed
US-9713595-B2 Sustained-release composition and method for producing the same TAKEDA PHARMACEUTICALS COMPANY LIMITED (JP) 2017-07-25 US disclosed
US-20170165204-A1 SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-06-15 US disclosed
US-9617303-B2 Sustained-release composition and method for producing the same TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-04-11 US disclosed
EP-1466596-B1 MICROSPHERE AND METHOD FOR PRODUCTION THEREOF TAKEDA PHARMACEUTICAL (JP) 2016-08-31 EP disclosed
EP-1297850-B1 MEDICINAL PREPARATIONS FOR TREATING SEX HORMONE-DEPENDENT DISEASES TAKEDA PHARMACEUTICAL (JP) 2015-08-19 EP disclosed
US-20150080322-A1 SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-03-19 US disclosed
US-8927016-B2 Producing a sustained-release preparation TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-01-06 US disclosed
US-8921326-B2 Sustained-release composition and method for producing the same TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-12-30 US disclosed
EP-1297850-A1 MEDICINAL PREPARATIONS FOR TREATING SEX HORMONE-DEPENDENT DISEASES Takeda Chemical Industries, Ltd. (JP) 2003-04-02 EP disclosed
EP-1049458-B1 LYOPHILIZATION METHOD FOR SUSTAINED-RELEASE PREPARATIONS TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-03-26 EP disclosed
WO-2003002092-A2 CONTROLLED RELEASE COMPOSITION COMPRISING LACTIC ACID POLYMER AND HYDROXYNAPHTHOIC ACID, AND METHOD OF PRODUCING THE SAME TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-09 WO disclosed
EP-1197208-A1 SUSTAINED RELEASE COMPOSITIONS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-04-17 EP disclosed
EP-1158014-A1 PROCESS FOR PRODUCING POLYMER Takeda Chemical Industries, Ltd. (JP) 2001-11-28 EP disclosed
EP-1136079-A1 AGENTS FOR RETARDING CHANGE OF HORMONE-DEPENDENT CANCER INTO HORMONE-INDEPENDENT CANCER Takeda Chemical Industries, Ltd. (JP) 2001-09-26 EP disclosed
EP-1049458-A1 LYOPHILIZATION METHOD FOR SUSTAINED-RELEASE PREPARATIONS Takeda Chemical Industries, Ltd. (JP) 2000-11-08 EP disclosed
EP-1048301-A1 SUSTAINED RELEASE COMPOSITIONS, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2000-11-02 EP disclosed
WO-1999037288-A1 LYOPHILIZATION METHOD FOR SUSTAINED-RELEASE PREPARATIONS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-07-29 WO disclosed
WO-1998032423-A1 SUSTAINED-RELEASE MICROSPHERES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-07-30 WO disclosed